Company Overview
AEON is a Japanese holding company spanning supermarkets, general merchandise stores, drugstores and pharmacies, shopping malls, consumer finance, entertainment, specialty retail and Asian operations. Fiscal 2026 operating revenue was ¥10.72 trillion, but scale obscures the investment case: most sales earn very thin margins, while most profit comes from health and wellness, property development and finance. The shares are worth more than their ¥1,250 market price only if those higher-return businesses produce substantially more cash attributable to AEON shareholders while food retail stops consuming the improvement. ([aeon.info](https://www.aeon.info/ir/individual/results/?utm_source=openai))
How the Company Makes Money
Households pay AEON for food, apparel, household goods, medicines and services; mall tenants pay rent and related charges; cardholders and borrowers pay interest and fees. The economic engine is not grocery revenue. In fiscal 2026, GMS, supermarkets and discount stores generated about ¥7.10 trillion, or 66% of group revenue, but only ¥58.5 billion of operating profit, with margins between 0.6% and 1.7%. Health and wellness, financial services and shopping-center development generated only 24% of revenue but ¥184.2 billion, or 68% of consolidated operating profit.
Profit persists where AEON has assets that are difficult to reproduce quickly: a nationwide store and mall network, purchasing scale, Topvalu private-label products, prescription-pharmacy relationships, tenant locations, payment data and a large card and deposit customer base. Drugstores retain customers through convenience and recurring prescriptions; malls combine established catchments with tenant turnover and entertainment; finance monetizes transactions created elsewhere in the group. Food retail has weaker protection because customers can switch easily and competitors can match prices. Wages, logistics, utilities and procurement costs therefore absorb small changes in gross margin.
Growth is capital intensive. Fiscal 2026 capital expenditure was ¥543.0 billion versus ¥362.9 billion of depreciation; the developer and GMS segments alone spent ¥324.2 billion. Financial services also employed ¥8.31 trillion of assets requiring funding and regulatory capital. Furthermore, only ¥1.22 trillion of the group’s ¥2.20 trillion net assets belonged to owners of the parent; the rest was largely non-controlling interests. Consolidated profit and cash therefore overstate what AEON common shareholders can ultimately receive.
Why the Stock Fell
AEON completed a three-for-one split in September 2025 and broadened access to its popular shopping benefits. Retail demand helped carry the post-split shares to ¥2,920 on November 25, 2025. At ¥1,250 on October 1, 2026, the verified decline is 57.2%. Even measured against the eventual fiscal 2026 EPS of ¥26.87, the peak represented approximately 109 times earnings. The fall was primarily the unwinding of an exceptional valuation rather than a collapse in revenue or operating profit. ([stockanalysis.com](https://stockanalysis.com/quote/tyo/8267/history/?utm_source=openai))
The subsequent disclosures exposed weak per-share conversion. Tsuruha and Welcia integrated on December 1, 2025, and AEON made Tsuruha a 50.9%-owned subsidiary in January 2026. During fiscal 2026, long-term borrowings rose by ¥440.1 billion and goodwill by ¥116.4 billion. On April 9, 2026, AEON forecast fiscal 2027 operating profit to rise 25.7% to ¥340 billion, yet profit attributable to owners was forecast to increase only 0.4% to ¥73 billion. The July quarter then showed that consolidated improvement was coming from health and wellness, malls, entertainment and finance: GMS, supermarkets and discount stores together lost about ¥4.0 billion. The market correctly shifted attention from consolidated growth to earnings per share and cash ownership. ([aeon.info](https://www.aeon.info/news/release_101301/?utm_source=openai))
What the Market Is Assuming
At the October 1, 2026 valuation date, ¥1,250 per share and a ¥3.458 trillion market capitalization imply 2.767 billion shares. The price is approximately 47 times both fiscal 2026 reported parent profit and fiscal 2027 guidance. A conditional reverse valuation requiring an 8% return and 3% perpetual growth needs about ¥173 billion of immediately distributable annual earnings. A 10% return with 2% growth needs ¥277 billion. Both are far above the ¥73 billion company forecast.
The supplied deterministic model reports ¥381.421 billion of owner earnings, an 11.03% yield and 9.07-year payback. That is the strongest cheapness argument, but its FCF conversion is unavailable and the number cannot be treated as parent-distributable cash. Fiscal 2026 operating cash flow of ¥1.127 trillion benefited from ¥319.2 billion of movements in other assets and liabilities and ¥216.0 billion from trade payables, while investing cash flow was negative ¥1.089 trillion. Banking flows, acquisition activity and minority ownership further complicate access. If the full ¥381.421 billion were genuinely recurring and distributable, a 10% capitalization would produce ¥3.81 trillion, or about ¥1,380 per share. The disclosed parent earnings and cash-flow composition do not yet support that interpretation.
The supplied ¥2.204 trillion book value and 1.57 times price-to-book ratio also provide no clear floor because that book value includes non-controlling interests. Net cash was negative ¥1.152 trillion, NCAV negative ¥3.488 trillion and the modeled liquidation value negative ¥3.297 trillion. AEON must be valued as an earning business, not as a collection of assets available for distribution.
Temporary or Structural?
The verdict is mixed, with more ESSENCE than TIME at the current valuation. The temporary elements are integration costs, inflationary pressure, supermarket restructuring and investment ahead of productivity gains. The Tsuruha-Welcia combination has a credible mechanism: joint procurement, private-label development, logistics and store-density efficiencies. AEON estimates approximately ¥50 billion of synergies over three years, and first-quarter health-and-wellness operating profit rose 216% to ¥26.7 billion. ([aeon.info](https://www.aeon.info/wp-content/uploads/2025/04/20250411RE_1.pdf?utm_source=openai))
The structural problem is that revenue growth has not reliably produced shareholder earnings. Fiscal 2026’s record operating profit still represented only a 2.52% margin, below the 2.63% earned in fiscal 2024. Supermarket and discount operations cannot consistently pass wage, logistics and product inflation to price without sacrificing traffic. Meanwhile, profitable finance, property and drugstore subsidiaries require capital and contain minority interests. The acquisition strategy has improved consolidated mix, but borrowing and the supplied 7.11% share-count increase reduce the benefit per existing share.
AEON can endure a slow recovery because it has extensive funding access, banking deposits and recurring consumer demand, but survival is not the hurdle. Parent profit must rise from ¥73 billion toward at least ¥150–175 billion without another material increase in shares or debt. The strongest contrary evidence is the fiscal 2030 plan targeting ¥530 billion of operating profit and roughly 9% ROE, supported by drugstore synergies, wholly owned mall and facilities operations, tax consolidation and Asian growth. If those measures double parent earnings while controlling reinvestment, the apparent structural damage would prove mostly transitional. ([aeon.info](https://www.aeon.info/wp-content/uploads/news/pdf/2026/05/260511R_2.pdf?utm_source=openai))
Is the Market Wrong? By How Much?
Valuation bridge. Fiscal 2026 reported parent profit was ¥72.7 billion, but it included a step-acquisition gain connected with Tsuruha. The cleaner starting point is fiscal 2027 company guidance of ¥73.0 billion. The scenarios translate fiscal 2030 operating profit into parent earnings after interest, tax and minorities. Maintenance capital expenditure is assumed to equal depreciation; growth investment is funded through retained earnings using the stated ROE and terminal-growth assumptions. This is favorable because fiscal 2026 capex exceeded depreciation by ¥180.1 billion. No stock-compensation add-back is made, no excess cash is added, and the 2.767 billion current share count captures the disclosed dilution.
| Scenario | Fiscal 2030 operating assumptions | Estimated equity value | Value per share | Versus ¥1,250 |
|---|---|---|---|---|
| Bear | ¥430bn operating profit; ¥100bn parent earnings; 10% required return; no terminal growth | ¥0.68tn | ¥250 | -80% |
| Base | Company’s ¥530bn operating-profit target; 30% conversion to ¥160bn parent earnings; 9% ROE; 8% return; 2% growth | ¥1.52tn | ¥550 | -56% |
| Bull | ¥600bn operating profit; unusually strong 42% conversion to ¥250bn parent earnings; 10% ROE; 6.5% return; 2.5% growth | ¥3.64tn | ¥1,320 | +5% |
The calculation capitalizes fiscal 2030 distributable earnings after retaining the amount required to support terminal growth, then discounts the result back four years. The base case already assumes AEON meets its operating-profit plan, improves parent conversion from the guided 21.5% to 30%, and sustains those economics. The market price is close to the bull case, which requires profit above the company plan, much better ownership and tax conversion, and a low required return.
The 57% share-price decline has removed the peak’s speculative excess but has not created a conventional margin of safety. Evidence of mispricing would require the supplied ¥381.421 billion owner-earnings figure to become demonstrably accessible to parent shareholders, or parent earnings to compound toward ¥250 billion without equivalent reinvestment, leverage or dilution. The assumption most threatening this conclusion is that drugstore synergies and group restructuring may improve bottom-line conversion far faster than the current guidance indicates.
Key Facts, Estimates, and Judgments
| Decision-critical test | Status and period | Result that would change the conclusion |
|---|---|---|
| Core food-retail profitability | Reported, Q1 fiscal 2027: GMS, SM and discount stores lost about ¥4.0bn combined | Combined margins above 1.5% for two consecutive half-years without increased working-capital usage |
| Profit conversion to AEON shareholders | Guidance, fiscal 2027: ¥73bn parent profit from ¥340bn operating profit, or 21.5% | Conversion sustainably exceeds 30% while annual share growth remains below 3% |
| Drugstore integration | Company estimate: approximately ¥50bn of synergies over three years | The synergy run-rate is achieved and produces visible parent earnings rather than only consolidated minority profit |
| Owner-earnings accessibility | Model estimate, fiscal 2026: ¥381.421bn; FCF conversion unavailable | Recurring parent-level cash after maintenance investment and minorities exceeds ¥175bn for two years |